The ABPI Research, Medical and Innovation Team works to improve the UK environment for the research, development and manufacturing of medicines.
The UK should aspire to nothing less than a health and care system that delivers the best patient outcomes in the world. We believe that a strong partnership between NHS and industry is the best way to improve outcomes for patients now and in the future.
The ABPI represents innovative research-based biopharmaceutical companies, large, medium and small, leading an exciting new era of biosciences in the UK. Through the ABPI Exam and ABPI Code of Practice we ensure representatives in the pharmaceutical industry act in an open, responsible and ethical way.
By working with patient organisations we can ensure that we are developing and delivering medicines which can make the most impact on people's health and wellbeing.
We have an interactive Resources for Schools website, with curriculum linked science content for students, teachers and parents.
The ABPI supports the training of medical representatives through distance learning and offers exams for representatives that comply with the ABPI Code of Practice requirements. Information on the exam is provided on the ABPI Exams website.
With 7,000 medicines and vaccines in the global pipeline, the future of health looks exciting. The pharmaceutical industry is pioneering new treatments and new technologies that will change the face of modern medicine. Explore just some of those areas here.
Medicines bring huge value to NHS patients. The development of new medicines is uncertain, costly, and involves significant rates of failure. Find out how pharmaceutical companies are pioneering R&D into the next generation of treatments.
Trailblazing scientists are the backbone of our industry. New pioneers are stepping into the shoes of Sir Alexander Fleming, Louis Pasteur and Henry Wellcome. But past challenges are different to those we face now. What we choose to do today will define the future of our industry and global health.